Viatris (VTRS): MYL boosts HCQ production for COVID-19 t...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	840
Posts	120476
Boards Moderated	18
Alias Born	09/05/2002

DewDiligence

Re: None

Thursday, 03/19/2020 5:24:46 PM

Thursday, March 19, 2020 5:24:46 PM

MYL boosts HCQ production for COVID-19 treatment:

https://www.prnewswire.com/news-releases/mylan-ramps-up-us-manufacturing-of-hydroxychloroquine-sulfate-tablets-to-meet-potential-covid-19-patient-needs-301027106.html

Mylan expects to be in a position to begin supplying product by mid-April, and with the active pharmaceutical ingredient that we currently have available, will be able to ramp up manufacturing to provide 50 million tablets to potentially treat a total of more than 1.5 million patients.

It's unclear from the excerpt above exactly how long it will take MYL to produce 50M tablets, but I presume they're talking about weeks rather than months.

Note: HCQ may work as a treatment for COVID-19 infection, but there is no practical way it can be used to prevent infection.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”